FindTrial
Sign In

To identify and study the most common high-risk HPV genotypes present among women in the Kumaon region. The study findings are crucial for developing targeted prevention and intervention strategies to improve womens health outcomes in the area.

Study on prevalence of Human Papillomavirus (HPV) and distribution of specific high risk genotypes of HPV among women of Kumaon - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093193
Enrollment
290
Registered
2025-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N879- Dysplasia of cervix uteri, unspecified Health Condition 2: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Department Of Health Research (DHR-ICMR)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married woman of 21 years or above, 2. Patients presenting with complaints of Excessive or abnormal discharge per vagina 3. Irregular or abnormal Bleeding per vagina spotting 4. Pain during coitus 5. Post coital bleeding 6. Lower abdominal pain 7. Cervix bleeds on touch 8. Unhealthy cervix on per speculum examination 9. Patient without any complaint 10. Belong to North India (by descent) 11. Giving informed consent

Exclusion criteria

Exclusion criteria: 1. Unmarried women 2. Pregnant women 3. Age less then 21 years 4. Not giving informed consent

Design outcomes

Primary

MeasureTime frame
The study will provide the burden of unhealthy cervix, with or without cervical dysplasia, along with pattern of HPV type in the region that will pave the way for tailor made policy for cervical cancer screening, HPV vaccination, management of cases.Timepoint: 36 months—

Secondary

MeasureTime frame
a) The study will provide estimate of unhealthy cervix conditions on female patients which will facilitate the identification of risk factors & the implementation of effective screening strategies, thereby enhancing early detection & treatment options within the healthcare system.Timepoint: 30 months;b) The findings related to the distribution & characterization of various high-risk HPV genotypes, including among the targeted demographic group.Timepoint: 36 months;c) Different local geographical area-based HPV prevalence identification in add-on to major high -risk genotyping may aid identification of hot-spot areas of HPV infection/prevalence.Timepoint: 36 months;d) The result will establish a specific pattern of HPV types prevalent in the region, which will facilitate the development of customized policies for cervical cancer screening & HPV vaccination initiatives.Timepoint: 36 months—

Countries

India

Contacts

Public ContactSomesh Mehra

Multidisciplinary Research Unit (MRU), Government Medical College Haldwani

drsomeshmehra@gmail.com9410431774

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026